BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15973444)

  • 1. Normal growth and regenerating ability of myoblasts from unaffected muscles of facioscapulohumeral muscular dystrophy patients.
    Vilquin JT; Marolleau JP; Sacconi S; Garcin I; Lacassagne MN; Robert I; Ternaux B; Bouazza B; Larghero J; Desnuelle C
    Gene Ther; 2005 Nov; 12(22):1651-62. PubMed ID: 15973444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The possible place of autologus cell therapy in facioscapulohumeral muscular dystrophy].
    Desnuelle C; Sacconi S; Marolleau JP; Larghero J; Vilquin JT
    Bull Acad Natl Med; 2005 Apr; 189(4):697-713; discussion 713-4. PubMed ID: 16245686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of mesoangioblasts from facioscapulohumeral muscular dystrophy muscle biopsies.
    Morosetti R; Mirabella M; Gliubizzi C; Broccolini A; Sancricca C; Pescatori M; Gidaro T; Tasca G; Frusciante R; Tonali PA; Cossu G; Ricci E
    Stem Cells; 2007 Dec; 25(12):3173-82. PubMed ID: 17761758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesoangioblasts from facioscapulohumeral muscular dystrophy display in vivo a variable myogenic ability predictable by their in vitro behavior.
    Morosetti R; Gidaro T; Broccolini A; Gliubizzi C; Sancricca C; Tonali PA; Ricci E; Mirabella M
    Cell Transplant; 2011; 20(8):1299-313. PubMed ID: 21176400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Premature proliferative arrest of cricopharyngeal myoblasts in oculo-pharyngeal muscular dystrophy: Therapeutic perspectives of autologous myoblast transplantation.
    Périé S; Mamchaoui K; Mouly V; Blot S; Bouazza B; Thornell LE; St Guily JL; Butler-Browne G
    Neuromuscul Disord; 2006 Nov; 16(11):770-81. PubMed ID: 17005403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation.
    Winokur ST; Chen YW; Masny PS; Martin JH; Ehmsen JT; Tapscott SJ; van der Maarel SM; Hayashi Y; Flanigan KM
    Hum Mol Genet; 2003 Nov; 12(22):2895-907. PubMed ID: 14519683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the RAG-1 as a suitable mouse model for mitochondrial DNA disease.
    Pye D; Watt DJ; Walker C; Lightowlers RN; Turnbull DM
    Neuromuscul Disord; 2004 May; 14(5):329-36. PubMed ID: 15099593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteopontin and skeletal muscle myoblasts: association with muscle regeneration and regulation of myoblast function in vitro.
    Uaesoontrachoon K; Yoo HJ; Tudor EM; Pike RN; Mackie EJ; Pagel CN
    Int J Biochem Cell Biol; 2008; 40(10):2303-14. PubMed ID: 18490187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heat shock treatment increases engraftment of transplanted human myoblasts into immunodeficient mice.
    Riederer I; Negroni E; Bigot A; Bencze M; Di Santo J; Aamiri A; Butler-Browne G; Mouly V
    Transplant Proc; 2008 Mar; 40(2):624-30. PubMed ID: 18374147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myoblasts from affected and non-affected FSHD muscles exhibit morphological differentiation defects.
    Barro M; Carnac G; Flavier S; Mercier J; Vassetzky Y; Laoudj-Chenivesse D
    J Cell Mol Med; 2010 Jan; 14(1-2):275-89. PubMed ID: 18505476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. iMyoblasts for ex vivo and in vivo investigations of human myogenesis and disease modeling.
    Guo D; Daman K; Chen JJ; Shi MJ; Yan J; Matijasevic Z; Rickard AM; Bennett MH; Kiselyov A; Zhou H; Bang AG; Wagner KR; Maehr R; King OD; Hayward LJ; Emerson CP
    Elife; 2022 Jan; 11():. PubMed ID: 35076017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplantation of normal and DMD myoblasts expressing the telomerase gene in SCID mice.
    Seigneurin-Venin S; Bernard V; Moisset PA; Ouellette MM; Mouly V; Di Donna S; Wright WE; Tremblay JP
    Biochem Biophys Res Commun; 2000 Jun; 272(2):362-9. PubMed ID: 10833419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SORBS2 transcription is activated by telomere position effect-over long distance upon telomere shortening in muscle cells from patients with facioscapulohumeral dystrophy.
    Robin JD; Ludlow AT; Batten K; Gaillard MC; Stadler G; Magdinier F; Wright WE; Shay JW
    Genome Res; 2015 Dec; 25(12):1781-90. PubMed ID: 26359233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FRG2, an FSHD candidate gene, is transcriptionally upregulated in differentiating primary myoblast cultures of FSHD patients.
    Rijkers T; Deidda G; van Koningsbruggen S; van Geel M; Lemmers RJ; van Deutekom JC; Figlewicz D; Hewitt JE; Padberg GW; Frants RR; van der Maarel SM
    J Med Genet; 2004 Nov; 41(11):826-36. PubMed ID: 15520407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinal vascular disease and the pathogenesis of facioscapulohumeral muscular dystrophy. A signalling message from Wnt?
    Fitzsimons RB
    Neuromuscul Disord; 2011 Apr; 21(4):263-71. PubMed ID: 21377364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RAGE-NF-kappaB pathway activation in response to oxidative stress in facioscapulohumeral muscular dystrophy.
    Macaione V; Aguennouz M; Rodolico C; Mazzeo A; Patti A; Cannistraci E; Colantone L; Di Giorgio RM; De Luca G; Vita G
    Acta Neurol Scand; 2007 Feb; 115(2):115-21. PubMed ID: 17212615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myoblast transfer therapy: is there any light at the end of the tunnel?
    Mouly V; Aamiri A; Périé S; Mamchaoui K; Barani A; Bigot A; Bouazza B; François V; Furling D; Jacquemin V; Negroni E; Riederer I; Vignaud A; St Guily JL; Butler-Browne GS
    Acta Myol; 2005 Oct; 24(2):128-33. PubMed ID: 16550930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy.
    Osborne RJ; Welle S; Venance SL; Thornton CA; Tawil R
    Neurology; 2007 Feb; 68(8):569-77. PubMed ID: 17151338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mitotic clock in skeletal muscle regeneration, disease and cell mediated gene therapy.
    Mouly V; Aamiri A; Bigot A; Cooper RN; Di Donna S; Furling D; Gidaro T; Jacquemin V; Mamchaoui K; Negroni E; Périé S; Renault V; Silva-Barbosa SD; Butler-Browne GS
    Acta Physiol Scand; 2005 May; 184(1):3-15. PubMed ID: 15847639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction of the FSHD myoblast differentiation defect by fusion with healthy myoblasts.
    Dib C; Bou Saada Y; Dmitriev P; Richon C; Dessen P; Laoudj-Chenivesse D; Carnac G; Lipinski M; Vassetzky YS
    J Cell Physiol; 2016 Jan; 231(1):62-71. PubMed ID: 26218298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.